NCT03857997View on ClinicalTrials.gov

Contribution of High Throughput RNA Sequencing Combined With Sequencing of Whole Genomes in the Diagnosis of Intellectual Disability

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 4, 2019

Primary Completion Date

December 27, 2019

Study Completion Date

February 2, 2021

Conditions

Patients With Intellectual Disabilities Without an Obvious Clinical DiagnosisPatients With Normal Array CGH and Previous Negative Genetic Investigations (WES-solo or WES-trio)

Interventions

BIOLOGICAL

Patient blood sampling

sequencing by WGS and RNA-seq

BIOLOGICAL

Parents blood sampling

sequencing by WGS

Trial Locations (1)

21000

Chu Dijon Bourgogne, Dijon

All Listed Sponsors

lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT03857997 - Contribution of High Throughput RNA Sequencing Combined With Sequencing of Whole Genomes in the Diagnosis of Intellectual Disability | Biotech Hunter | Biotech Hunter